XPOF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xponential Fitness Inc (XPOF) is not a strong buy at this moment for a beginner investor with a long-term strategy. While there is some speculative upside due to the strategic review process, the company's weak financial performance, ongoing legal investigations, and lack of clear positive catalysts make it a risky investment. Holding off on this stock until there is more clarity on the strategic review outcome and financial improvements is advisable.
The stock is currently in a pre-market phase with a price of $7.58, up 0.40%. The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 92.734, signaling an overbought condition. The stock is trading near its resistance level of R1: 7.409, with key support at S1: 5.812. Moving averages are converging, suggesting a lack of strong directional trend.
The board has initiated a strategic review process, which could lead to a sale or merger, potentially unlocking shareholder value. Hedge funds have significantly increased their buying activity (+342.65% over the last quarter).
Analysts have downgraded the stock and lowered price targets, citing operational challenges and lack of near-term growth visibility. Insider trading trends are neutral, providing no additional confidence.
In Q4 2025, revenue dropped by -1.02% YoY to $82.96M. Net income declined by -8.26% YoY to -$41.27M, and EPS fell by -14.60% YoY to -1.17. However, gross margin improved by 10.52% YoY to 76.68%, indicating some operational efficiency gains.
Analysts have mixed to negative views on Xponential Fitness. Recent price target changes include increases by Roth Capital ($7 to $8) and Northland ($7 to $9), but UBS, Stifel, and others have lowered targets, citing operational challenges and weak performance. The consensus rating is neutral, with no strong buy recommendations.
